Industry

Visterra

A biologics company in Massachusetts combining computational design and AI with antibody engineering to treat immune-mediated diseases.

Location: Waltham, MA, USA
Website
1 model

Models (1)

BindCraft

EPFL / SIB Swiss Institute of Bioinformatics / University of Zurich / Wageningen University & Research / University at Buffalo / Lausanne University Hospital / MIT / Visterra

Released September 30, 2024

De novo protein binder design pipeline that hallucinates binders through frozen AlphaFold2 weights, averaging a 46% experimental success rate.

Protein